tobramycin has been researched along with Prostatic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bismuth, R; Fredj, G; Khoury, S; Rigat, B | 1 |
| Cormio, L; La Forgia, P; Ruutu, M; Siitonen, A; Talja, M; Törmälä, P | 1 |
2 other study(ies) available for tobramycin and Prostatic Diseases
| Article | Year |
|---|---|
[Comparison of serum and prostatic levels of tobramycin].
Topics: Biological Assay; Humans; Immunoenzyme Techniques; Male; Prostate; Prostatic Diseases; Tobramycin | 1984 |
Immersion in antibiotic solution prevents bacterial adhesion onto biodegradable prostatic stents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Biodegradation, Environmental; Ciprofloxacin; Equipment Contamination; Escherichia coli; Humans; Lactic Acid; Male; Polyesters; Polyglycolic Acid; Polymers; Prostatic Diseases; Stents; Tobramycin | 1997 |